Key Insights The projected fair value for Becton Dickinson is US$341 based on 2 Stage Free Cash Flow to Equity ...

Becton Dickinson ( ($BDX) ) has issued an announcement. On October 15, 2025, BD announced a CFO transition plan as Chris ...

Fintel reports that on October 16, 2025, RBC Capital reiterated coverage of Becton, Dickinson and (NYSE:BDX) with a Sector ...

Becton Dickinson & Co's (NYSE: BDX) short interest as a percent of float has fallen 10.81% since its last report. According to exchange reported data, there are now 3.83 million shares sold short, ...

Becton Dickinson CFO Chris DelOrefice will step down Dec. 5 as BD reports strong fiscal 2025 sales and appoints Vitor Roque interim CFO.

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

Williams, and Becton, Dickinson and Company sport a market-doubling 2.5% dividend yield. Learn more about CVX, SHW, and BDX ...

Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.

OneMain is a scale leader in nonprime personal lending. The macro backdrop has given us the opportunity to own OneMain at an ...

These Dividend Aristocrat stocks offer the great value and entry points for investors seeking dependable income with growth ...

Fate Therapeutics, Inc. (NASDAQ: FATE) (the Company), a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular ...

Becton Dickinson stock fell in premarket trading after announcing its CFO transition, despite strong year-end results.